There are over 4,500 Bristol graduates residing in the US. The University of Bristol Foundation Inc helps them to stay connected to each other, as well as to the University itself.
The University of Bristol Foundation Inc purpose is to:
- Act as Bristol’s lead partner in the US, supporting the delivery of the US Plan to build profile, reputation and philanthropic support for the University
- Advise and assist the Global Engagement Division and North America Office in the development of strategic plans in the US
- Agree allocation of 501 (c)(3) funding
- Support and work closely with stakeholders and alumni in the US to foster a strong community of active alumni supporters
The support of the University of Bristol Foundation Inc is crucial for many of the University’s worthy causes. This includes the Sanctuary Scholarships programme, which provides funds to enable people from asylum-seeking and refugee communities to come and study at the University. The Foundation also plays an instrumental part in funding some of the University’s most crucial research and in supporting early career researchers to become leaders in their field. Support given to the University by the University of Bristol Foundation Inc has also greatly bolstered the work of the Cabot Institute and significantly advanced the University’s environmental work.
Supporters of the University of Bristol created the University of Bristol Foundation Inc in 1992. The Foundation is governed by an independent Board of Directors. Board Directors play a key role in building an engaged, supportive and inclusive alumni community in the US, by working in partnership with alumni, the Global Engagement Division, the North America Office and the wider University. Directors provide expert advice, strategic insight and specialist contributions, acting in an ambassadorial capacity within the US alumni community and for the University.
The University of Bristol Foundation Inc is a US non-profit organisation, tax exempt under Section 501 (c)(3) of the US Internal Revenue Code. Gifts to the University of Bristol Foundation Inc are deductible to the extent allowed by law. All funds donated to the University of Bristol Foundation Inc. are at the discretion of the Board and are also eligible for matched giving by many US corporations. The University of Bristol Foundation Inc is a United States Corporation organized in Massachusetts.
University of Bristol Foundation Inc Board Members
Timothy Parton (BSc 1986)
Timothy Parton studied Economics and Accounting at the University and graduated in 1986. He is a managing director and a portfolio manager within the JPMorgan Asset Management U.S. Equity Group. An employee since 1986, Tim has managed a variety of Small, Mid and All-Cap portfolios over his career. Tim has been managing the J.P. Morgan Mid Cap Growth strategy since November 2001 and the J.P. Morgan Growth Advantage strategy since its inception in September 2005. In addition, Tim is a co-portfolio manager of the J.P. Morgan Equity Focus strategy, the JPMorgan American Investment Trust and the J.P. Morgan Mid Cap Equity strategy.
Tim holds a B.Sc. in Economics & Accounting from the University of Bristol. He is a member of the New York Society of Security Analysts and The CFA Institute and is a CFA charter holder. In addition to serving on the board of the University of Bristol US Foundation, Tim is a director of African People & Wildlife, a conservation organization based in northern Tanzania with activities in southern Africa.
Geraldine Keefe (MEng 2000)
Geraldine is co-head of Investment Banking for the Midwest Region and a member of the Industrials Group within the Investment Banking Division. She joined Goldman Sachs in 2000 as an analyst on the UK Advisory team in London and transferred to the Industrials Group in San Francisco in 2004. After leaving in 2006 to pursue an MBA, Geraldine rejoined the firm in 2008 as a member of the Americas Special Situations Group in the Securities Division in New York, where she worked on minority equity investments in privately owned businesses. She returned to the Industrials Group in 2009 and was named vice president the same year.
Geraldine was named managing director in 2013 and partner in 2016. Geraldine serves on the Board of Trustees of the Chicago Symphony Orchestra, on the Posse Foundation Chicago Advisory Board and on the board of the University of Bristol US Foundation. She is also a member of the Civic Committee of the Commercial Club of Chicago. Geraldine earned a master’s degree in Aerospace Engineering from the University of Bristol in 2000 and an MBA, with high distinction, from Harvard Business School in 2008.
Dr Una Ryan OBE (BSc 1963, Hon DSc 2009)
Dr. Una Ryan has extensive experience leading public, private and non-profit companies. She serves on the boards of Cortexyme (CRTX), RenovoRx (RNXT), Elemental Machines, Cambridge in America and the University of Bristol US Foundation. Dr. Ryan is an LP at Breakout Ventures and Lionheart Ventures. She focuses on women-led ventures as Managing Director of Golden Seeds, and partner in Astia Angels. She has a portfolio of early-stage companies in San Francisco and Boston.
She was a serial CEO of Diagnostics for All, Waltham Technologies and AVANT (now CLDX). Continuing a career translating science to successful businesses, Dr. Ryan is now translating science to art and founded ULUX bringing science perspectives to the art world.
Dr. Ryan holds a PhD from Cambridge University, BSc degrees and an honorary DSc from the University of Bristol. Her academic career included Professorships of Medicine at Miami, Washington and Boston Universities. She held the titles Howard Hughes Investigator, American Heart Association Established Investigator, and NIH MERIT Awardee. She received numerous honors including Albert Einstein Award for outstanding achievement in the life sciences, Cartier Award, World Economic Forum Tech Pioneer and Order of the British Empire (OBE).
Tim Ritchie (BA 1978)
After graduating from the University of Bristol in 1978, Tim joined Barclays Bank International. His banking career continued until 2010 and included time in the US (Boston and New York) and London. He set up the bank’s loan syndications team in New York and moved to London in 1994 to become global head of loan syndications. Later known as Global Loans, this business grew within Barclays Capital to take responsibility for the execution and distribution of corporate and leveraged loans originated by the Barclays Group, as well as loan trading and structured trade finance, and worked closely with the bank’s loan portfolio managers. During this period, Tim spent time on the Management Committee of Barclays Capital and served as Chairman of the Wholesale Committee of the British Bankers Association.
Tim was also the founding chairman of the Loan Market Association, a position which he held from 1996 to 2005. The Loan Market Association, which recently celebrated its 25th anniversary, is the trade body for the EMEA syndicated loan market and now has over 750 member institutions, including banks, institutional investors, borrowers, law firms, rating agencies and other service providers.
Tim retired from Barclays in 2010 and his primary residence is on Cape Cod. He enjoys playing tennis and golf regularly. He and his wife Judi are collectors of contemporary art and have a close affiliation with the School of the Museum of Fine Arts, which is now part of Tufts University. Tim also serves on the school’s Advisory Board.
Leslie Stevens (BSc 1975)
Leslie graduated from Bristol with a first class honours degree in mathematics. She continued her studies at the University of Michigan with a MS of Computer Science and holds an MSc of Business from Pace University.
Leslie began her career as a systems engineer at Bell Laboratories, progressing into senior roles in software-related businesses at Bell Laboratories, AT&T and NCR. After leaving AT&T, Leslie joined Stevens Institute of Technology as Industry Professor in the School of Systems and Enterprises and taught online graduate students in Systems Engineering for over 10 years, retiring in January 2020. For the last 7 years, Leslie has been involved in combating climate change with organisations 350nyc.org and Climate Reality, with a particular focus on transport systems for New York City.
Leslie lives in New Jersey. She was a director for the Farmstead Arts Center, a historic property now used as a local arts center. She was elected to the Bernards Township Board of Education as well as the boards for the Cancer Hope Network and the Wall Street Technology Association. She also enjoys playing the guitar, the arts, fitness and reading.
Anna Rainsford (LLB 2015)
Anna is a legal counsel at asset management firmGrantham Mayo Van Otterloo & Co LLC (GMO). She was previously an associate at Latham & Watkins in London and transferred to the Boston office in 2019. After leaving in 2020 to pursue a master’s in law, Anna rejoined Latham& Watkins in 2021 where she worked in the private equity/mergers and acquisitions team until joining GMO in 2022.
Anna earned an LLB in Law from the University of Bristol in 2015 and an LLM from the University of Columbia in 2021, where she graduated from as a Harlan Fiske Stone Scholar. Anna is admitted to practice as an attorney in Massachusetts and as a solicitor in England and Wales.
Matthew Rosamond (BSc 2001)
Matt is the Chief Financial Officer of the Icahn School of Medicine at Mount Sinai, a role he assumed in 2021, having previously been the Chief Operating Officer of Mount Sinai Doctors Faculty Practice. Prior to these roles Matt was the co-founder and CFO of Sema4, a genetic testing and healthcare data company,and alsospent over 10 years at PricewaterhouseCoopers, providing advisory services to corporate and private equity clients.
Matt graduated from the University of Bristol in 2001 with a BSc in Economics and Politics and subsequently earned an MBA from NYU Stern School of Business and a CFA charter. In addition to the University of Bristol Foundation, Matt serves on the board of the Biomedical Research Association of New York, The Mitral Foundation and Castlevax. Matt lives in Westchester County, New Yorkand enjoys playing soccer, tennis and platform tennis.
Ben Quarmby (BSc 2001)
Ben Quarmby is a partner with the litigation boutique of MoloLamken LLP. He focuses on busine disputes and intellectual property litigation and has represented clients as lead trial counsel in federal and state trial courts around the United States. His clients include US corporations, individuals and family offices, as well as many foreign companies, particularly from Japan and France.
Ben teaches US intellectual property law at the International Centre for Intellectual Property Studies (CEIPI) in France. He frequently publishes on topics including patent, trademark and trade secret law as well as art law, fashion law, the General Data Protection Regulation (GDPR), artificial intelligence, social media, and privacy. He is also a regular speaker on issues such as third-party litigation funding, developments in patent, trademark and copyright law, and international arbitration.
In addition to serving as a Director for the University of Bristol Foundation, Ben also serves on the New York University Langone Family Advisory Council and its Diabetes Family Advisory Council. He is interested in all issues relating to Type 1 diabetes- medical, technological, social and beyond.
Dr Krai Chatamra (BSc 1990, PhD 1994)
Dr Chatamra is Vice President of Clinical Development at Intrance Medical Systems, a biopharmaceutical company, where he leads clinical development efforts for Parkinson’s disease treatments. He has previously held leadership roles at Theravance, Lundbeck, AbbVie, Abbott, Pfizer and Merck. Dr Chatamra has over 25 years of experience in pharmaceutical drug development where he has been responsible for developing and advancing therapeutic indications, particularly in Parkinson’s disease, oncology, neuroscience, cardiology and respiratory medicine. He led the successful clinical development program for levodopa-carbidopa intestinal gel for advanced Parkinson’s disease, which is now approved in more than 70 countries, including the US.
He graduated from the University of Bristol in 1990 with a BSc in Physiology and returned to complete his PhD in the same subject in 1994.